These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25645108)

  • 1. Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.
    Pernin V; Belin L; Cottu P; Bontemps P; Lemanski C; De La Lande B; Baumann P; Missohou F; Levy C; Peignaux K; Reynaud-Bougnoux A; Denis F; Gobillion A; Bollet M; Vago NA; Dendale R; Campana F; Fourquet A; Kirova YM
    Br J Radiol; 2015 Apr; 88(1048):20140800. PubMed ID: 25645108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with bevacizumab.
    Goyal S; Rao MS; Khan A; Huzzy L; Green C; Haffty BG
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):408-13. PubMed ID: 20452134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M; Cutuli B; Cellier P; Campion L; Le Blanc M
    Radiat Oncol; 2015 Aug; 10():161. PubMed ID: 26238442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
    Clément-Zhao A; Tanguy ML; Cottu P; De La Lande B; Bontemps P; Lemanski C; Baumann P; Savignoni A; Levy C; Peignaux K; Reynaud-Bougnoux A; Gobillion A; Kirova Y
    PLoS One; 2019; 14(8):e0221816. PubMed ID: 31469859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Miny-Buffet J; Favre A; Azria D; Body G; Le Floch O; Calais G
    Cancer Radiother; 2006 Jun; 10(4):158-67. PubMed ID: 16632399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer.
    Pernin V; Belin L; Cottu P; Bontemps P; Lemanski C; De La Lande B; Baumann P; Missohou F; Levy C; Peignaux K; Bougnoux P; Denis F; Bollet M; Dendale R; Vago NA; Campana F; Fourquet A; Kirova YM
    Breast; 2014 Dec; 23(6):816-20. PubMed ID: 25260760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial.
    Cameron D; Brown J; Dent R; Jackisch C; Mackey J; Pivot X; Steger GG; Suter TM; Toi M; Parmar M; Laeufle R; Im YH; Romieu G; Harvey V; Lipatov O; Pienkowski T; Cottu P; Chan A; Im SA; Hall PS; Bubuteishvili-Pacaud L; Henschel V; Deurloo RJ; Pallaud C; Bell R
    Lancet Oncol; 2013 Sep; 14(10):933-42. PubMed ID: 23932548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study.
    Dautruche A; Belin L; Cottu P; Bontemps P; Lemanski C; de la Lande B; Baumann P; Missohou F; Lévy C; Peignaux K; Reynaud-Bougnoux A; Denis F; Gobillion A; Pernin V; Kirova Y
    Cancer Radiother; 2018 May; 22(3):222-228. PubMed ID: 29650388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study.
    Caussa L; Kirova YM; Gault N; Pierga JY; Savignoni A; Campana F; Dendale R; Fourquet A; Bollet MA
    Eur J Cancer; 2011 Jan; 47(1):65-73. PubMed ID: 20843680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute cardiotoxicity with concurrent trastuzumab and radiotherapy including internal mammary chain nodes: a retrospective single-institution study.
    Shaffer R; Tyldesley S; Rolles M; Chia S; Mohamed I
    Radiother Oncol; 2009 Jan; 90(1):122-6. PubMed ID: 18976826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
    Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA
    Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.
    Guenzi M; Blandino G; Vidili MG; Aloi D; Configliacco E; Verzanini E; Tornari E; Cavagnetto F; Corvò R
    Radiat Oncol; 2015 Aug; 10():177. PubMed ID: 26289040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study.
    Fiets WE; van Helvoirt RP; Nortier JW; van der Tweel I; Struikmans H
    Eur J Cancer; 2003 May; 39(8):1081-8. PubMed ID: 12736107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmastectomy radiotherapy in intermediate risk stage I-II breast cancer patients.
    Mladenovic J; Susnjar S; Gavrilovic D; Borojevic N
    J BUON; 2007; 12(2):215-20. PubMed ID: 17600875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study.
    Belkacémi Y; Gligorov J; Ozsahin M; Marsiglia H; De Lafontan B; Laharie-Mineur H; Aimard L; Antoine EC; Cutuli B; Namer M; Azria D
    Ann Oncol; 2008 Jun; 19(6):1110-6. PubMed ID: 18344537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
    Toledano A; Garaud P; Serin D; Fourquet A; Bosset JF; Breteau N; Body G; Azria D; Le Floch O; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):324-32. PubMed ID: 16542788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831.
    Halyard MY; Pisansky TM; Dueck AC; Suman V; Pierce L; Solin L; Marks L; Davidson N; Martino S; Kaufman P; Kutteh L; Dakhil SR; Perez EA
    J Clin Oncol; 2009 Jun; 27(16):2638-44. PubMed ID: 19349549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
    Azria D; Belkacemi Y; Romieu G; Gourgou S; Gutowski M; Zaman K; Moscardo CL; Lemanski C; Coelho M; Rosenstein B; Fenoglietto P; Crompton NE; Ozsahin M
    Lancet Oncol; 2010 Mar; 11(3):258-65. PubMed ID: 20138810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.